My Portfolio
+
LINK YOUR PORTFOLIO

ALK-Abello A/S 0OIR-GB:London Stock Exchange

RT Quote | Exchange | DKK
Last | 5:32 PM BST
149.45UNCH (UNCH)
52 week range
149.45 - 269.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close149.45
  • 52 Week High269.90
  • 52 Week High Date05/27/26
  • 52 Week Low149.45
  • 52 Week Low Date06/03/26

Latest On ALK-Abello A/S

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend1.60
  • Dividend Yield1.07%
  • Beta-

Latest On ALK-Abello A/S

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close149.45
  • 52 Week High269.90
  • 52 Week High Date05/27/26
  • 52 Week Low149.45
  • 52 Week Low Date06/03/26
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend1.60
  • Dividend Yield1.07%
  • Beta-

RATIOS/PROFITABILITY

  • EPS (TTM)5.80
  • P/E (TTM)25.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/17/2026
  • Div Amount1.60
  • Split Date-
  • Split Factor-

Profile

MORE
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product...
Anders Hedegaard
Independent Chairman of the Board
Peter Halling
President, Chief Executive Officer
Claus Solje
Executive Vice President, Chief Financial Officer
Henriette Mersebach
Executive Vice President - Research and Development
Flora Beiche-Scholz
Executive Vice President - Commercial Operations, Europe
Address
Boege Alle 6-8
Hoersholm
2970
Denmark